Login

Andrews Liver Salts Effervescent Powder

*
General Sale: Non-prescription
  • andrewseff250g.png

Updated on 27 June 2023

File name

Master-ie-pil-andrews_-Approved 20June2023.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder

Free text change information supplied by the pharmaceutical company

Update to section 6 MAH now Haleon Ireland Limited12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

Updated on 27 June 2023

File name

MASTER-ie-spc-andrews--appoved 20June2023.pdf

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Update to MAH in Section 7 to Haleon

Update to Revision of text in Section 10

Updated on 09 January 2023

File name

MASTER-ie-spc-andrews-678-043-001-approved-July2015.pdf

Reasons for updating

  • Document format updated

Legal category:Supply through general sale

Updated on 03 May 2016

File name

PIL_9241_862.pdf

Reasons for updating

  • New PIL for new product

Updated on 03 May 2016

Reasons for updating

  • Change to MA holder contact details

Updated on 10 July 2015

Reasons for updating

  • New SPC for new product

Legal category:Supply through general sale

Updated on 10 July 2015

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 7

Marketing Authorisation Holder address updated to:

12 Riverwalk,

Citywest Business Campus,

Dublin 24,

Ireland

Updated on 22 May 2015

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.8 - Addition of HPRA reporting statement

Updated on 21 May 2015

Reasons for updating

  • Change to side-effects

Updated on 03 December 2012

Reasons for updating

  • Change due to harmonisation of PIL

Updated on 13 August 2010

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to information about pregnancy or lactation

Updated on 24 August 2009

Reasons for updating

  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.3: Addition of hypersensitivity as a contraindication.
Section 4.4: Addition of warning re sugar intolerances.
Section 4.6: Addition of warnings re pergnancy.

Updated on 20 February 2009

Reasons for updating

  • Change to section 4.3 - Contraindications
  • Change to section 4.4 - Special warnings and precautions for use

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

Section 4.3
the following text is added:
 

This product should not be given to patients with a hypersensitivity to any component of Andrews Liver Salts or any previous hypersensitivity to Andrews Liver Salts.

 
Section 4.4
the following text is added:
 

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

Updated on 28 August 2007

Reasons for updating

  • Improved electronic presentation

Updated on 30 May 2007

Reasons for updating

  • Improved electronic presentation

Updated on 22 May 2007

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

6.5 Nature and Contents of Container

Removal of reference to 'integral 5 ml spoon'

Updated on 20 April 2007

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 10 - Date of revision of the text

Legal category:Supply through general sale

Free text change information supplied by the pharmaceutical company

1. Name of the medicinal product

Change name to: Andrews Liver Salts Effervescent Powder

6.4 Special Precautions for Storage

Amend wording as follows: Keep the container tightly closed.

6.5 Nature and Contents of Container

Include statement: Not all pack sizes may be marketed.

10. Date of revision of text

April 2007

Updated on 18 November 2004

Reasons for updating

  • New PIL for medicines.ie

Updated on 20 August 2003

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through general sale

Updated on 19 August 2003

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through general sale

Updated on 12 August 2003

Reasons for updating

  • Improved electronic presentation

Legal category:Supply through general sale

Updated on 25 June 2003

Reasons for updating

  • New SPC for medicines.ie

Legal category:Supply through general sale